EU Watchdog Approves Pfizer Covid Pill
Faizan Hashmi Published January 27, 2022 | 09:05 PM
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe
The Hague, (APP - UrduPoint / Pakistan Point News - 27th Jan, 2022 ) :The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
Studies showed the drug called Paxlovid reduces hospitalisation and death in patients at risk of severe Covid, and may also be effective against the Omicron variant.
Pills are seen as a potentially huge step in ending the pandemic as they can be taken at home, rather than in hospital.
"Paxlovid is the first antiviral medicine to be given by mouth that is recommended in the EU for treating Covid-19," the European Medicines Agency (EMA) said in a statement.
The United States, Canada and Israel are among a handful of countries to have already given the green light to the Pfizer treatment.
The European Commission must now formally authorise the drug but that is a rubber-stamp procedure that usually takes hours or days.
"Paxlovid is the first oral antiviral for home use in our portfolio, and has the potential to make a real difference for persons at high risk of progression to severe Covid," EU Health Commissioner Stella Kyriakides said in a statement.
"We have also seen the promising evidence regarding Paxlovid's effectiveness against Omicron and other variants." The Pfizer treatment is a combination of a new molecule, PF-07321332, and HIV antiviral ritonavir, that are taken as separate tablets.
The EMA said it "recommended authorising Paxlovid for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe".
EMA experts looked at a study "showing that treatment with Paxlovid significantly reduced hospitalisations or deaths in patients who have at least one underlying condition putting them at risk of severe Covid-19".
Patients were given the pill within five days of developing symptoms and over the following month only 0.8 percent of the 1,039 people studied ended up in hospital, compared with 6.3 percent of those who received a placebo.
There were no deaths in the Paxlovid group and nine deaths in the placebo group, the EMA said.
In December the EMA cleared individual states to decide whether to make early emergency use of Paxlovid, but held off on deciding on full authorisation across the 27-nation bloc.
The watchdog is still weighing a similar application for US drugmaker Merck's anti-Covid pill.
Unlike vaccines, the Pfizer treatment does not target the ever-evolving spike protein which the coronavirus uses to invade cells.
It should therefore in theory be more variant-proof, and the company has said preliminary lab studies have backed up that hypothesis.
Related Topics
Recent Stories
PSX witnesses positive trend today
PM Shehbaz meets CJP Isa to address IHC judges’ concerns
Pakistan vows to bring to justice perpetrators, abettors of Bisham terrorist att ..
May 9 riots: SC allows conditionally to military courts to deliver reserved verd ..
Interior Minister arrives in Peshawar after Shangla suicide attack
OPPO Reno 11 F 5G: Setting New Records as Pakistan's Most Beloved Smartphone Lin ..
PCB dismisses FICA's claims of unpaid dues in PSL
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 28 March 2024
Today Gold Rate in Pakistan 28 March 2024
Niger says US to submit plan to 'disengage' troops
Venezuelan opposition registers unknown poll contender after obstacles
Van Aert breaks collarbone, ribs in Flanders fall
More Stories From World
-
Gabon's post-coup reform efforts under fire
5 minutes ago -
Meet China's first corgi police dog
54 minutes ago -
Singapore sees sharp decrease in PE investment last year
55 minutes ago -
China's role model selection for Q1 2024 kicks off
55 minutes ago -
Australians tighten belt as higher grocery prices bite: survey
55 minutes ago -
ChiNext Index closes higher Thursday
55 minutes ago
-
China to improve management of midwife service
1 hour ago -
China to lift anti-dumping tariffs on Australian wine
1 hour ago -
Seoul bus drivers' strike ends with wage agreement
1 hour ago -
Revolt at Ecuador jail where powerful gang leader escaped
1 hour ago -
US-Israel rift heads for moment of truth over Rafah
2 hours ago -
Russian bombs turn Ukraine border village into 'hell'
3 hours ago